We are live on
!
Find out more
RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
23.37%
This Fund
S&P 500
This Quarter
Est. Return
-10.89%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$754M
AUM Growth
-$97.5M
(-11%)
Cap. Flow
+$8.85M
Cap. Flow
% of AUM
1.17%
Top 10 Holdings %
Top 10 Hldgs %
34.4%
Holding
222
New
21
Increased
61
Reduced
89
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
New York Times
NYT
|
+$1.65M |
| 2 |
Teladoc Health
TDOC
|
+$1.6M |
| 3 |
Merck
MRK
|
+$1.47M |
| 4 |
Amalgamated Financial
AMAL
|
+$1.45M |
| 5 |
Nike
NKE
|
+$1.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$2.89M |
| 2 |
IBM
IBM
|
+$2.63M |
| 3 |
J.M. Smucker
SJM
|
+$2.51M |
| 4 |
Gilead Sciences
GILD
|
+$1.28M |
| 5 |
COL
Rockwell Collins
COL
|
+$1.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.69% |
| 2 | Technology | 17.94% |
| 3 | Industrials | 12.44% |
| 4 | Financials | 11.62% |
| 5 | Communication Services | 10.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Mastercard
MA
$493B
| $34.1M | 4.53% |
180,967
-2,508
| -1% | -$498K |
|
2
Apple
AAPL
$4.57T
| $29.2M | 3.87% |
739,448
+12,024
| +2% | +$583K |
|
3
Johnson & Johnson
JNJ
$625B
| $28.6M | 3.8% |
221,791
-2,465
| -1% | -$344K |
|
4
Walt Disney
DIS
$181B
| $26.6M | 3.53% |
242,608
+4,514
| +2% | +$513K |
|
5
Novartis
NVS
$297B
| $25.5M | 3.38% |
331,360
-477
| -0.1% | -$37.1K |
|
6
Danaher
DHR
$144B
| $24.4M | 3.24% |
266,922
+12,932
| +5% | +$1.17M |
|
7
PayPal
PYPL
$50.5B
| $23.9M | 3.17% |
284,205
+6,425
| +2% | +$535K |
|
8
Illumina
ILMN
$28.4B
| $23.1M | 3.06% |
79,117
+599
| +0.8% | +$186K |
|
9
Alphabet (Google) Class A
GOOGL
$4.33T
| $22.1M | 2.93% |
422,700
+9,120
| +2% | +$493K |
|
10
Abbott
ABT
$187B
| $21.9M | 2.9% |
302,364
+3,139
| +1% | +$221K |
|
11
Analog Devices
ADI
$190B
| $21.8M | 2.9% |
254,345
+6,297
| +3% | +$545K |
|
12
Canadian National Railway
CNI
$76.6B
| $21.6M | 2.87% |
291,440
+12,802
| +5% | +$1.06M |
|
13
Rockwell Automation
ROK
$49B
| $21.5M | 2.86% |
143,064
+3,002
| +2% | +$501K |
|
14
Stryker
SYK
$130B
| $20.5M | 2.72% |
130,905
+7,965
| +6% | +$1.33M |
|
|
15
Nike
NKE
$61.9B
| $19.7M | 2.62% |
266,343
+18,450
| +7% | +$1.38M |
|
16
AptarGroup
ATR
$8.61B
| $19.1M | 2.53% |
202,726
+6,355
| +3% | +$648K |
|
17
Xylem
XYL
$28.1B
| $17.7M | 2.35% |
265,258
+10,450
| +4% | +$723K |
|
18
Automatic Data Processing
ADP
$108B
| $15.3M | 2.04% |
117,060
-2,897
| -2% | -$409K |
|
|
XLNX
19
DELISTED
Xilinx Inc
XLNX
| $14.7M | 1.95% |
172,661
+2,051
| +1% | +$171K |
|
|
FISV
20
Fiserv Inc
FISV
$27.9B
| $13M | 1.73% |
177,041
+11,157
| +7% | +$862K |
|
21
Microsoft
MSFT
$3.71T
| $11.2M | 1.49% |
110,718
+4,514
| +4% | +$484K |
|
22
Procter & Gamble
PG
$339B
| $11.1M | 1.48% |
120,999
-4,866
| -4% | -$435K |
|
23
MarketAxess Holdings
MKTX
$5.72B
| $10.5M | 1.39% |
49,646
+2,781
| +6% | +$576K |
|
24
CVS Health
CVS
$122B
| $10.3M | 1.37% |
157,276
-3,982
| -2% | -$297K |
|
25
Waste Management
WM
$91B
| $10.2M | 1.36% |
114,801
+5,615
| +5% | +$504K |
|
Similar funds
SC
CAM
TCM
RCM
LGM
MYAM
HA
NIM
Reynders McVeigh Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Reynders McVeigh Capital Management held 222 positions worth $754M, down 11% from $851M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Reynders McVeigh Capital Management's Q4 2018 filing shows 21 new, 61 increased, 89 reduced and 16 closed positions. Its largest new stake was T-Mobile US: 12,000 shares worth $763K. The largest sale was Celgene Corp, an estimated $2.89M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 29% a quarter earlier, followed by Technology and Industrials.
- Reynders McVeigh Capital Management's largest Q4 2018 buy was T-Mobile US: 12,000 shares worth $763K.
- Reynders McVeigh Capital Management added most to New York Times in Q4 2018, an estimated $1.65M increase.
- Reynders McVeigh Capital Management's biggest Q4 2018 reduction was Celgene Corp, cutting an estimated $2.89M.
- Reynders McVeigh Capital Management fully exited Rockwell Collins in Q4 2018, selling an estimated $1.23M.
- Reynders McVeigh Capital Management's ten largest holdings make up 34% of its $754M portfolio in Q4 2018.
- Reynders McVeigh Capital Management opened 21 new positions and closed 16 in Q4 2018.
- Reynders McVeigh Capital Management's portfolio value fell 11% quarter-over-quarter to $754M.
Based on Reynders McVeigh Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.